Healwell Al Inc T.AIDX

Target price and rating from Eight Capital...

[zack50]

Eight Capital’s Christian Sgro increased his HEALWELL AI Inc. target to $4 from $2.50 with a “buy” rating. The average is $2.61.

“HEALWELL announced the $24.5-million acquisition of VeroSource, an innovative, cloud-based digital health tool that services the public sector. The deal is accretive at up to 3.1 times estimated 2024 revenue, building on HEALWELL’s digital footprint and software operating profile. With more data points around pharma commercialization, and AI valuations at premiums (Cohere raised at 142 times TTM revenue), we expect continued momentum in HEALWELL’s share price as the company attacks a unique opportunity in healthcare AI. With much of the VeroSource consideration to be issued as equity, we model over $20-milllion of cash for HEALWELL to continue scaling its top-line, with $50-million-plus of runrate revenue in sight with more deals like VeroSource.”